Of note, due to the detection of class-defining gene rearrangements, MECOM and NUP98, four cases initially diagnosed as MDS were reclassified to AML, based on ICC and WHO-HAEM5 classifications. This evidence concerns the gene MECOM and intrahepatic cholangiocarcinoma.